Article

Incidence, severity, longitudinal trends and predictors of acute and chronic oxaliplatin-induced peripheral neuropathy in Taiwanese patients with colorectal cancer.

Eur J Cancer Care (Engl). 2019 Mar 1; 28 (2): e12976.
Randomized Controlled Trial

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.

Neurotherapeutics. 2018 Jan 1; 15 (1): 178-189.
Article

Real world, open label experience with lacosamide against acute painful oxaliplatin-induced peripheral neurotoxicity.

J. Peripher. Nerv. Syst. 2020 Jun 1; 25 (2): 178-183.